Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif., June 2, 2017 Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreementto expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint... Read more

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass., June 2, 2017 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences: Jefferies 2017 Healthcare Conference, New York, NYThursday, June 8, 2017, at 1:30 p.m. Eastern TimeFrank Laukien, President and Chief Executive OfficerJuergen Srega, President, Bruker CALID Group William Blair 37th Annual Growth Stock Conference, Chicago, ILTuesday, June... Read more

Agilent Technologies Inspires at ASMS 2017 with Innovative Technology Solutions

New Solutions for Mass Spectrometry Further Enhance Lab Efficiency and Productivity SANTA CLARA, Calif., June 1, 2017 Agilent Technologies Inc. (NYSE: A) today announced that it will showcase a range of new and innovative technology solutions at the American Society for Mass Spectrometry (ASMS) Conference being held June 3 through June 8 in Indianapolis, Indiana.... Read more

Bruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting

NEW ORLEANS, June 1, 2017 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe 2017 meeting (www.asm.org), Bruker introduces major innovations for strain typing, hospital hygiene and infection control. The novel, bench-top IR Biotyper system for microbial strain typing is based on Fourier-Transform Infrared (FTIR) spectroscopy technology, and complements Bruker’s world-leading MALDI Biotyper mass... Read more

Philips and Illumina team up with Navican, an Intermountain Healthcare Company, to Accelerate the Delivery of Precision Medicine to Health Systems Worldwide

– New “turnkey” approach to precision medicine seeks to deliver Intermountain’s best practices into a streamlined service to be integrated at the point of care – Solution’s goal is to benefit late stage cancer patients through advanced analytics and expert decision support, combined with providing better access to targeted treatments and clinical trials NEWS PROVIDED... Read more

Waters and Wyatt Collaborate to Advance Polymer Analysis and Biopharmaceutical Characterization Studies

Coupling of technologies delivers valuable information 5x faster than conventional size exclusion chromatography (SEC) MILFORD, Mass.–(BUSINESS WIRE)–May 31, 2017– Waters Corporation (NYSE:WAT) announced that it entered into a Co-Marketing agreement with Wyatt Technology to advance the analysis of synthetic polymers and biotherapeutic proteins. By pairing Waters® ACQUITY® UPLC® and Waters® ACQUITY® Advanced Polymer Chromatography® (APC™)... Read more

Phenomenex Opens New Gas Chromatography Research and Manufacturing Facility

Torrance, Calif. (May 30, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the opening of a new manufacturing and development facility dedicated to the company’s gas chromatography (GC) columns, marketed under the Zebron™ brand name. The 15,000-square-foot facility, which was designed and extensively... Read more

Illumina to Webcast Live Presentation at the Goldman Sachs Global Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 13, 2017. The live webcast is scheduled to begin at 2:40 PM PT and will feature a brief overview of the company by Francis deSouza, President and CEO, followed by a... Read more